脓毒症患者新发心房颤动的结局:225,841例患者的系统评价与荟萃分析
该系统评价与荟萃分析纳入13项研究、共225,841例脓毒症患者,评估新发心房颤动与预后之间的关系。汇总结果显示,新发房颤与院内死亡(OR 2.09;95%CI 1.53-2.86;95%CI 1.81-3.29;95%CI 1.13-3.14;新发房颤发生率从轻度脓毒症的1.9%至脓毒性休克的46.0%不等,且与ICU及住院时间延长、房颤复发率更高相关。提示脓毒症新发房颤是需关注并适当管理的临床问题。
要点
- 新发房颤发生率从轻度脓毒症1.9%至脓毒性休克46.0%不等。
- 新发房颤患者ICU及住院时间更长、房颤复发率更高。
适用人群与场景
- 脓毒症患者(纳入13项研究、共225,841例患者),涵盖轻度脓毒症至脓毒性休克不同病情阶段;原文未明确排除人群及具体急诊/ICU/院前场景。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:系统评价与荟萃分析,纳入13项独立研究、共225,841例脓毒症患者。
- 新发房颤发生率从轻度脓毒症1.9%至脓毒性休克46.0%不等;与无房颤者相比,新发房颤患者ICU及住院时间更长、房颤复发率更高。
- 原文未报告关键次要终点的具体效应量、不良事件及异质性检验结果。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析(基于13项观察性研究的汇总分析);原文未明确证据等级或推荐强度。
- 局限:原文未讨论纳入研究的设计类型、异质性、发表偏倚等具体局限;汇总OR来自观察性研究,不能推断因果关系。
对床旁实践的改变
- 脓毒症患者出现新发房颤提示院内死亡、出院后死亡及卒中风险增高,应予以关注并适当管理以预防不良预后;原文未给出具体管理方案。
- 脓毒性休克患者新发房颤发生率可达46.0%,需警惕;原文未提供筛查或治疗的具体建议。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The outcomes of new-onset atrial fibrillation (AF) during sepsis are inconsistent and inconclusive. This meta-analysis aims to provide a comprehensive description of the impact of new-onset AF on the prognosis of sepsis.
METHODS: Three electronic databases (PubMed, Embase, and the Cochrane Library) were searched for relevant studies. Meta-analysis was performed using odds ratios (OR) and 95% confidence intervals (CI) as effect measures.
RESULTS: A total of 225,841 patients from 13 individual studies were incorporated to the meta-analysis. The summary results revealed that new-onset AF during sepsis was associated with increased odds of in-hospital mortality (pooled OR: 2.09; 95% CI: 1.53-2.86; p < 001), post-discharge mortality (pooled OR: 2.44; 95% CI: 1.81-3.29; p < .001), and stroke (pooled OR:1.88; 95% CI: 1.13-3.14; p < .05). Results also indicated that the incidence of new-onset AF varied from 1.9% for mild sepsis to 46.0% for septic shock. Furthermore, compared to those without AF, people with new-onset AF had longer ICU and hospital stays, as well as a higher recurrence of AF.
CONCLUSIONS: New-onset AF is frequently associated with adverse outcomes in patients with sepsis. This is a clinical issue that warrants more attention and should be managed appropriately to prevent poor prognosis.
参考来源
- Xiao FP, Chen MY, Wang L, et al. Outcomes of new-onset atrial fibrillation in patients with sepsis: A systematic review and meta-analysis of 225,841 patients. Am J Emerg Med. 2021. PMID: 33429188. doi:10.1016/j.ajem.2020.12.062
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。